Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Plos One|December 16, 2016
A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic CardiomyopathyJoshua A Stern, Svetlana Markova, Yu Ueda, et al.Cancer Treatment and Research Communications|May 9, 2022
Trimodality therapy for patients with stage III non-small-cell lung cancer: A comprehensive surveillance, epidemiology, and end results analysisVincent P Grzywacz, Thomas J Quinn, Muayad F Almahariq, et al.Clinical Endocrinology|January 3, 2014
Different cut-off values of the insulin tolerance test, the high-dose short Synacthen test (250 μg) and the low-dose short Synacthen test (1 μg) in assessing central adrenal insufficiencyHwa Y Cho, Jung H Kim, Sang W Kim, et al.Circulation Research|August 2, 2008
The helix-loop-helix factors Id3 and E47 are novel regulators of adiponectinAmanda C Doran, Nahum Meller, Alexis Cutchins, et al.The American Journal of Cardiology|September 20, 2005
Intravascular ultrasound assessment of ruptured atherosclerotic plaques in left main coronary arteriesPawel Tyczynski, Jerzy Pregowski, Gary S Mintz, et al.The Patient|June 20, 2018
Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic ManifestationsAmy Simon, Farrah Pompilus, William Querbes, et al.Journal of the American College of Cardiology|April 3, 2014
Anti-PCSK9 monotherapy for hypercholesterolemia: the MENDEL-2 randomized, controlled phase III clinical trial of evolocumabMichael J Koren, Pernille Lundqvist, Michael Bolognese, et al.Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 25, 2018
Role of Holmium laser enucleation of the prostate to increase cancer detection rate in patients with gray-zone PSA levelKi H Kim, Sang W Kim, Hee S Son, et al.Development (Cambridge, England)|August 4, 2004
The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction systemIvan P G Moskowitz, Anne Pizard, Vickas V Patel, et al.Clinical Cardiology|June 21, 2012
Design and rationale of the LAPLACE-TIMI 57 trial: a phase II, double-blind, placebo-controlled study of the efficacy and tolerability of a monoclonal antibody inhibitor of PCSK9 in subjects with hypercholesterolemia on background statin therapyPayal Kohli, Nihar R Desai, Robert P Giugliano, et al.Pageof 5